Rankings
▼
Calendar
TKNO Q3 2020 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$135M
Q3 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$9M
Gross Profit
$5M
56.6% margin
Operating Income
$2M
24.0% margin
Net Income
$2M
17.1% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
+48.6%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$3M
Stock-Based Comp.
$31,000
← FY 2020
All Quarters
Q4 2020 →